SBRT and Oncolytic Virus Therapy Before Pembrolizumab for Metastatic TNBC and NSCLC
Condition(s):Metastatic Non-small Cell Lung Cancer; Metastatic Triple-negative Breast CancerLast Updated:February 20, 2024Completed
Hide Studies Not Open or Pending
Condition(s):Metastatic Non-small Cell Lung Cancer; Metastatic Triple-negative Breast CancerLast Updated:February 20, 2024Completed
Condition(s):Glioblastoma Multiforme; Astrocytoma, Grade IIILast Updated:August 31, 2023Recruiting
Condition(s):Herpes ZosterLast Updated:December 29, 2023Completed
Condition(s):Bell’s PalsyLast Updated:June 4, 2008Completed
Condition(s):Critical IllnessLast Updated:January 12, 2015Completed
Condition(s):Herpes Simplex Virus KeratitisLast Updated:January 14, 2022Withdrawn
Condition(s):Waldenstrom’s MacroglobulinemiaLast Updated:March 15, 2024Active, not recruiting
Condition(s):Malignant Glioma; Recurrent EpendymomaLast Updated:August 25, 2023Completed
Condition(s):Herpes Simplex Virus 2Last Updated:January 14, 2019Completed
Condition(s):High-risk Prostate Cancer; Prostate CancerLast Updated:April 6, 2021Unknown status
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.